ORPP logo
Image from Google Jackets

Cardiovascular Prevention and Rehabilitation in Practice.

By: Contributor(s): Material type: TextTextPublisher: Newark : John Wiley & Sons, Incorporated, 2020Copyright date: ©2015Edition: 2nd edDescription: 1 online resource (337 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781118458686
Subject(s): Genre/Form: Additional physical formats: Print version:: Cardiovascular Prevention and Rehabilitation in PracticeDDC classification:
  • 616.12
LOC classification:
  • RA776.9 .C373 2020
Online resources:
Contents:
Cover -- Title Page -- Copyright Page -- Contents -- Foreword -- List of Contributors -- Preface -- Chapter 1 Cardiovascular Disease Prevention and Rehabilitation -- 1.1 Rationale and Aims -- 1.2 The Burden of CVD -- 1.3 Defining CR and Cardiovascular Prevention and Rehabilitation -- 1.4 The Compelling Case for Cardiovascular Prevention and Rehabilitation -- 1.5 Service Provision and Uptake -- 1.6 Employing Evidence-Based Approaches to Increase Participation -- 1.7 Future Perspectives -- 1.8 Conclusion -- References -- Chapter 2 Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation -- 2.1 Rationale and Aims -- 2.2 Six Standards to Achieve High Quality Cardiovascular Prevention and Rehabilitation -- 2.3 The Core Components -- 2.3.1 Health Behaviour Change and Education -- 2.3.2 Lifestyle Risk Factor Management -- 2.3.3 Psychosocial Health -- 2.3.4 Medical Risk Management -- 2.3.5 Long-Term Strategies -- 2.3.6 Audit and Evaluation -- References -- Chapter 3 Delivering Quality Standards -- 3.1 Rationale and Aims -- 3.2 Maintaining Evidence-Based Practice -- 3.3 Standard 1: The Delivery of Six Core Components by a Qualified and Competent Multidisciplinary Team, Led by a Clinical Coordinator -- 3.4 Standard 2: Prompt Identification, Referral, and Recruitment of Eligible Patient Populations -- 3.5 Standard 3: Early Initial Assessment of Individual Patient Needs Which Informs the Agreed Personalised Goals that are Reviewed Regularly -- 3.6 Standard 4: Early Provision of a Structured Cprp, with a Defined Pathway of Care, Which Meets the Individual's Goals and is Aligned with Patient Preference and Choice -- 3.6.1 Identifying and Referring Patients -- 3.6.2 Manage the Referral and Recruitment of Patients -- 3.6.3 Assessing for and Delivering a Comprehensive CPRP.
3.6.4 Standard 5: Upon Programme Completion, a Final Assessment of Individual Patient Needs and Demonstration of Sustainable Health Outcomes -- 3.6.5 Standard 6: Registration and Submission of Data to the NACR and Participation in the National Certification Programme (NCP_CR) -- 3.6.6 Audit -- 3.6.7 Certification -- 3.6.8 Certification in the UK -- 3.6.9 What Are 'Minimum Standards'? -- 3.7 Conclusion -- References -- Chapter 4 Health Behaviour Change and Education -- 4.1 Rationale and Aims -- 4.1.1 What Do We Mean by Health Behaviour Change? -- 4.1.2 Why Is this Component Necessary? -- 4.1.3 Who Will Lead the Component within the Cardiovascular Prevention and Rehabilitation Programme? -- 4.2 Health Behaviour Change - Theoretical Foundations -- 4.3 Health Behaviour Change - Additional Concepts -- 4.3.1 Habit Formation -- 4.3.2 Implementation Intentions -- 4.3.3 Motivational Interviewing -- 4.3.4 Solution-focused Approaches -- 4.3.5 Illness Representations -- 4.3.6 Rapport Building -- 4.3.7 Effective Communication -- 4.4 Health Behaviour Change - Translating Theory into Practice -- 4.4.1 Motivational Interviewing -- 4.4.2 Cardiac Misconceptions and Illness Representations -- 4.4.3 Managing Misconceptions -- 4.5 Bringing it all Together - Goal‐Setting as a Practical Example -- 4.5.1 Principles of Goal-setting -- 4.5.2 Goal-setting as a Process -- 4.5.3 Supporting Goal Achievement -- 4.5.4 If-Then Plans -- 4.5.5 Maintenance of Goal Achievement -- 4.6 Improving Adherence to Treatment Recommendations -- 4.7 The Role of Social Support in Health Behaviour Change -- 4.7.1 Overprotection -- 4.7.2 Social Control -- 4.7.3 The Value of Engaging Others in Cardiovascular Prevention and Rehabilitation -- 4.8 Education in Cardiovascular Prevention and Rehabilitation -- 4.8.1 What Do We Mean by 'Patient Education'? -- 4.8.2 How Do Adults Learn?.
4.8.3 Tips for Group-based Education Sessions -- 4.8.4 Patient Education Materials -- 4.8.5 Principles for Developing Education Materials -- 4.9 Flexibility of Approaches to Cardiovascular Prevention and Rehabilitation - Why Do we Need a Menu of Options? -- 4.10 Maximising Group Dynamics - Tips for Successful Group Support -- 4.10.1 The Group Experience -- 4.10.2 Progress Feedback -- 4.11 Closed Versus Open Groups -- 4.12 How Will the Component Be Assessed and Monitored? -- 4.12.1 Evaluation of the Intervention -- 4.12.2 Consideration for Applications to Other Long-term Conditions -- 4.13 Conclusion -- References -- Chapter 5a Achieving Long-term Abstinence from Tobacco Use in Patients in a Cardiovascular Prevention and Rehabilitation Setting -- 5a.1 Rationale and Aims -- 5a.2 Dependence on Tobacco -- 5a.3 Assessment -- 5a.3.1 Status of Use -- 5a.3.2 Measuring Dependence -- 5a.3.3 Assessing Motivation to Quit -- 5a.3.4 Past Quit Attempts -- 5a.3.5 Psychological Co-morbidities -- 5a.4 Providing Support -- 5a.4.1 Opportunities for Smoking Cessation in a CPRP Setting -- 5a.4.2 Principles of a Withdrawal-oriented Approach -- 5a.4.3 Behavioural Support -- 5a.4.4 Pharmacological Agents -- 5a.5 Varenicline -- 5a.5.1 What Is it? -- 5a.5.2 How Does it Work? -- 5a.5.3 How Is it Used? -- 5a.5.4 Reducing Smoking with Varenicline -- 5a.5.5 Is it Safe? -- 5a.5.6 Are there any Side Effects? -- 5a.5.7 Ending Treatment -- 5a.6 Nicotine Replacement Therapy -- 5a.6.1 What Is it? -- 5a.6.2 How Does it Work? -- 5a.6.3 How Is it Used? -- 5a.6.4 'Cut Down to Stop' with NRT -- 5a.6.5 Is it Safe? -- 5a.6.6 Are there any Side Effects? -- 5a.7 Combining Varenicline with Combination NRT -- 5a.8 Bupropion -- 5a.8.1 What Is It and How Does It Work? -- 5a.8.2 How Is It Used? -- 5a.8.3 Safety and Side Effects -- 5a.9 Efficacy and Safety -- 5a.10 Electronic Cigarettes.
5a.11 Conclusion -- 5a.12 Component Leaders Within a CPRP -- 5a.13 Weight Gain and Smoking Cessation -- 5a.14 Harm Reduction -- Chapter 5b Diet and Weight Management -- 5b.1 Rationale and Aims -- 5b.2 Influences of Dietary Intake -- 5b.2.1 Question Style Influences Accuracy of Dietary Intake Reporting -- 5b.3 Assessment Methods of Dietary Intake -- 5b.3.1 Recall -- 5b.3.2 Recorded Methods -- 5b.4 Assessment of Body Composition -- 5b.4.1 Body Mass Index (BMI) -- 5b.4.2 Waist Circumference -- 5b.5 Components of Cardioprotective Dietary Advice -- 5b.5.1 Mediterranean Diet -- 5b.5.2 Fats -- 5b.5.3 Fruit and Vegetables -- 5b.5.4 Whole Grains and Fibre -- 5b.5.5 Nuts -- 5b.5.6 Salt -- 5b.5.7 Sugar -- 5b.5.8 Alcohol -- 5b.6 Weight Loss, Maintenance, and Avoidance of Cycling, Including Pharmacological Support -- 5b.6.1 Avoidance of Weight Cycling -- 5b.6.2 How Is Realistic Weight Loss Achieved? -- 5b.6.3 Weight Maintenance -- 5b.6.4 Pharmacotherapy Input -- 5b.6.5 Tailored Advice -- 5b.7 Common Misconceptions and Frequently Asked Questions -- 5b.7.1 Is Chocolate Good for the Heart? -- 5b.7.2 Are any Supplements Useful? -- 5b.7.3 Can I Still Eat Fruit and Vegetables Now I Take Warfarin? -- 5b.7.4 Is Coffee Bad for the Heart? -- 5b.7.5 Can Soya Lower Cholesterol? -- 5b.7.6 How Many Eggs Can I Eat a Week? -- 5b.7.7 Do I Need to Buy Plant Stanol/Sterol Enriched Margarine? -- 5b.7.8 If I Heat my Oil Too High when Cooking, Will it Become Harmful? -- 5b.7.9 Are Artificial Sweeteners Safe? -- 5b.7.10 I Read in the Newspaper that Eating XYZ Is Bad for my Heart, Is that True? -- 5b.7.11 I Don't Understand Food Labelling -- 5b.7.12 Can I Drink Grapefruit Juice? -- 5b.8 Relationship with Other Long‐Term Conditions -- 5b.8.1 Heart Failure -- 5b.8.2 Post-Surgery -- 5b.8.3 Chronic Kidney Disease -- 5b.8.4 Diabetes -- 5b.9 Conclusion -- References.
Chapter 5c Physical Activity and Exercise -- 5c.1 Rationale and Aims -- 5c.2 Consistency in Communicating Concepts to Patients -- 5c.3 Physical Activity Within the Context of Cardiovascular Health -- 5c.3.1 Preventing Cardiovascular Disease -- 5c.3.2 Physical Activity Within Rehabilitation and Secondary Prevention -- 5c.3.3 The Evidence Base Used in Educating Healthcare Professionals and Patients -- 5c.3.4 Plain Language Guidance and Education Points for Patients -- 5c.4 Moving from Traditional to Contemporary Models of Physical Activity and Rehabilitation -- 5c.4.1 Traditional Provision -- 5c.4.2 The Future Provision and Need for Early Commencement -- 5c.5 Key Issues for Early Commencement of Exercise -- 5c.5.1 Reducing Risk of Exertion-related Events -- 5c.5.2 Post-Surgery and Early Rehabilitation -- 5c.5.3 Post-Surgery, Early Aerobic Activity, and Strength Training -- 5c.5.4 Typical Post-Surgical Complications -- 5c.5.5 'Prehabilitation' Exercise for Surgical Patients -- 5c.5.6 Post-Angioplasty and Post-MI -- 5c.5.7 Post-angioplasty Complications -- 5c.5.8 Heart Failure -- 5c.5.9 Heart Rate and Perceived Exertion Use in Heart Failure -- 5c.5.10 Commencing Rehabilitation Prior to Optimisation of Heart Failure Medication -- 5c.6 Emerging Areas Related to Activity Intensity - From Sedentary Behaviour, Light Mobility, and Moderate Intensity to High Intensity Interval Training -- 5c.7 Assessing Functional Capacity and Physical Activity - Guidance, Prescription, and Risk Stratification Outcomes Evaluation and Audit -- 5c.8 Staffing, Core, and Quality Standards -- 5c.8.1 Location of Prevention and Rehabilitation Programmes -- 5c.9 Future Challenges for Exercise in Cardiovascular Disease Prevention and Rehabilitation -- 5c.10 Overarching Guidance -- 5c.11 Specific Physical Activity and Exercise Goals and Guidance -- 5c.12 Specific Exercise Sessions.
5c.13 Programme Outcomes.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Cover -- Title Page -- Copyright Page -- Contents -- Foreword -- List of Contributors -- Preface -- Chapter 1 Cardiovascular Disease Prevention and Rehabilitation -- 1.1 Rationale and Aims -- 1.2 The Burden of CVD -- 1.3 Defining CR and Cardiovascular Prevention and Rehabilitation -- 1.4 The Compelling Case for Cardiovascular Prevention and Rehabilitation -- 1.5 Service Provision and Uptake -- 1.6 Employing Evidence-Based Approaches to Increase Participation -- 1.7 Future Perspectives -- 1.8 Conclusion -- References -- Chapter 2 Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation -- 2.1 Rationale and Aims -- 2.2 Six Standards to Achieve High Quality Cardiovascular Prevention and Rehabilitation -- 2.3 The Core Components -- 2.3.1 Health Behaviour Change and Education -- 2.3.2 Lifestyle Risk Factor Management -- 2.3.3 Psychosocial Health -- 2.3.4 Medical Risk Management -- 2.3.5 Long-Term Strategies -- 2.3.6 Audit and Evaluation -- References -- Chapter 3 Delivering Quality Standards -- 3.1 Rationale and Aims -- 3.2 Maintaining Evidence-Based Practice -- 3.3 Standard 1: The Delivery of Six Core Components by a Qualified and Competent Multidisciplinary Team, Led by a Clinical Coordinator -- 3.4 Standard 2: Prompt Identification, Referral, and Recruitment of Eligible Patient Populations -- 3.5 Standard 3: Early Initial Assessment of Individual Patient Needs Which Informs the Agreed Personalised Goals that are Reviewed Regularly -- 3.6 Standard 4: Early Provision of a Structured Cprp, with a Defined Pathway of Care, Which Meets the Individual's Goals and is Aligned with Patient Preference and Choice -- 3.6.1 Identifying and Referring Patients -- 3.6.2 Manage the Referral and Recruitment of Patients -- 3.6.3 Assessing for and Delivering a Comprehensive CPRP.

3.6.4 Standard 5: Upon Programme Completion, a Final Assessment of Individual Patient Needs and Demonstration of Sustainable Health Outcomes -- 3.6.5 Standard 6: Registration and Submission of Data to the NACR and Participation in the National Certification Programme (NCP_CR) -- 3.6.6 Audit -- 3.6.7 Certification -- 3.6.8 Certification in the UK -- 3.6.9 What Are 'Minimum Standards'? -- 3.7 Conclusion -- References -- Chapter 4 Health Behaviour Change and Education -- 4.1 Rationale and Aims -- 4.1.1 What Do We Mean by Health Behaviour Change? -- 4.1.2 Why Is this Component Necessary? -- 4.1.3 Who Will Lead the Component within the Cardiovascular Prevention and Rehabilitation Programme? -- 4.2 Health Behaviour Change - Theoretical Foundations -- 4.3 Health Behaviour Change - Additional Concepts -- 4.3.1 Habit Formation -- 4.3.2 Implementation Intentions -- 4.3.3 Motivational Interviewing -- 4.3.4 Solution-focused Approaches -- 4.3.5 Illness Representations -- 4.3.6 Rapport Building -- 4.3.7 Effective Communication -- 4.4 Health Behaviour Change - Translating Theory into Practice -- 4.4.1 Motivational Interviewing -- 4.4.2 Cardiac Misconceptions and Illness Representations -- 4.4.3 Managing Misconceptions -- 4.5 Bringing it all Together - Goal‐Setting as a Practical Example -- 4.5.1 Principles of Goal-setting -- 4.5.2 Goal-setting as a Process -- 4.5.3 Supporting Goal Achievement -- 4.5.4 If-Then Plans -- 4.5.5 Maintenance of Goal Achievement -- 4.6 Improving Adherence to Treatment Recommendations -- 4.7 The Role of Social Support in Health Behaviour Change -- 4.7.1 Overprotection -- 4.7.2 Social Control -- 4.7.3 The Value of Engaging Others in Cardiovascular Prevention and Rehabilitation -- 4.8 Education in Cardiovascular Prevention and Rehabilitation -- 4.8.1 What Do We Mean by 'Patient Education'? -- 4.8.2 How Do Adults Learn?.

4.8.3 Tips for Group-based Education Sessions -- 4.8.4 Patient Education Materials -- 4.8.5 Principles for Developing Education Materials -- 4.9 Flexibility of Approaches to Cardiovascular Prevention and Rehabilitation - Why Do we Need a Menu of Options? -- 4.10 Maximising Group Dynamics - Tips for Successful Group Support -- 4.10.1 The Group Experience -- 4.10.2 Progress Feedback -- 4.11 Closed Versus Open Groups -- 4.12 How Will the Component Be Assessed and Monitored? -- 4.12.1 Evaluation of the Intervention -- 4.12.2 Consideration for Applications to Other Long-term Conditions -- 4.13 Conclusion -- References -- Chapter 5a Achieving Long-term Abstinence from Tobacco Use in Patients in a Cardiovascular Prevention and Rehabilitation Setting -- 5a.1 Rationale and Aims -- 5a.2 Dependence on Tobacco -- 5a.3 Assessment -- 5a.3.1 Status of Use -- 5a.3.2 Measuring Dependence -- 5a.3.3 Assessing Motivation to Quit -- 5a.3.4 Past Quit Attempts -- 5a.3.5 Psychological Co-morbidities -- 5a.4 Providing Support -- 5a.4.1 Opportunities for Smoking Cessation in a CPRP Setting -- 5a.4.2 Principles of a Withdrawal-oriented Approach -- 5a.4.3 Behavioural Support -- 5a.4.4 Pharmacological Agents -- 5a.5 Varenicline -- 5a.5.1 What Is it? -- 5a.5.2 How Does it Work? -- 5a.5.3 How Is it Used? -- 5a.5.4 Reducing Smoking with Varenicline -- 5a.5.5 Is it Safe? -- 5a.5.6 Are there any Side Effects? -- 5a.5.7 Ending Treatment -- 5a.6 Nicotine Replacement Therapy -- 5a.6.1 What Is it? -- 5a.6.2 How Does it Work? -- 5a.6.3 How Is it Used? -- 5a.6.4 'Cut Down to Stop' with NRT -- 5a.6.5 Is it Safe? -- 5a.6.6 Are there any Side Effects? -- 5a.7 Combining Varenicline with Combination NRT -- 5a.8 Bupropion -- 5a.8.1 What Is It and How Does It Work? -- 5a.8.2 How Is It Used? -- 5a.8.3 Safety and Side Effects -- 5a.9 Efficacy and Safety -- 5a.10 Electronic Cigarettes.

5a.11 Conclusion -- 5a.12 Component Leaders Within a CPRP -- 5a.13 Weight Gain and Smoking Cessation -- 5a.14 Harm Reduction -- Chapter 5b Diet and Weight Management -- 5b.1 Rationale and Aims -- 5b.2 Influences of Dietary Intake -- 5b.2.1 Question Style Influences Accuracy of Dietary Intake Reporting -- 5b.3 Assessment Methods of Dietary Intake -- 5b.3.1 Recall -- 5b.3.2 Recorded Methods -- 5b.4 Assessment of Body Composition -- 5b.4.1 Body Mass Index (BMI) -- 5b.4.2 Waist Circumference -- 5b.5 Components of Cardioprotective Dietary Advice -- 5b.5.1 Mediterranean Diet -- 5b.5.2 Fats -- 5b.5.3 Fruit and Vegetables -- 5b.5.4 Whole Grains and Fibre -- 5b.5.5 Nuts -- 5b.5.6 Salt -- 5b.5.7 Sugar -- 5b.5.8 Alcohol -- 5b.6 Weight Loss, Maintenance, and Avoidance of Cycling, Including Pharmacological Support -- 5b.6.1 Avoidance of Weight Cycling -- 5b.6.2 How Is Realistic Weight Loss Achieved? -- 5b.6.3 Weight Maintenance -- 5b.6.4 Pharmacotherapy Input -- 5b.6.5 Tailored Advice -- 5b.7 Common Misconceptions and Frequently Asked Questions -- 5b.7.1 Is Chocolate Good for the Heart? -- 5b.7.2 Are any Supplements Useful? -- 5b.7.3 Can I Still Eat Fruit and Vegetables Now I Take Warfarin? -- 5b.7.4 Is Coffee Bad for the Heart? -- 5b.7.5 Can Soya Lower Cholesterol? -- 5b.7.6 How Many Eggs Can I Eat a Week? -- 5b.7.7 Do I Need to Buy Plant Stanol/Sterol Enriched Margarine? -- 5b.7.8 If I Heat my Oil Too High when Cooking, Will it Become Harmful? -- 5b.7.9 Are Artificial Sweeteners Safe? -- 5b.7.10 I Read in the Newspaper that Eating XYZ Is Bad for my Heart, Is that True? -- 5b.7.11 I Don't Understand Food Labelling -- 5b.7.12 Can I Drink Grapefruit Juice? -- 5b.8 Relationship with Other Long‐Term Conditions -- 5b.8.1 Heart Failure -- 5b.8.2 Post-Surgery -- 5b.8.3 Chronic Kidney Disease -- 5b.8.4 Diabetes -- 5b.9 Conclusion -- References.

Chapter 5c Physical Activity and Exercise -- 5c.1 Rationale and Aims -- 5c.2 Consistency in Communicating Concepts to Patients -- 5c.3 Physical Activity Within the Context of Cardiovascular Health -- 5c.3.1 Preventing Cardiovascular Disease -- 5c.3.2 Physical Activity Within Rehabilitation and Secondary Prevention -- 5c.3.3 The Evidence Base Used in Educating Healthcare Professionals and Patients -- 5c.3.4 Plain Language Guidance and Education Points for Patients -- 5c.4 Moving from Traditional to Contemporary Models of Physical Activity and Rehabilitation -- 5c.4.1 Traditional Provision -- 5c.4.2 The Future Provision and Need for Early Commencement -- 5c.5 Key Issues for Early Commencement of Exercise -- 5c.5.1 Reducing Risk of Exertion-related Events -- 5c.5.2 Post-Surgery and Early Rehabilitation -- 5c.5.3 Post-Surgery, Early Aerobic Activity, and Strength Training -- 5c.5.4 Typical Post-Surgical Complications -- 5c.5.5 'Prehabilitation' Exercise for Surgical Patients -- 5c.5.6 Post-Angioplasty and Post-MI -- 5c.5.7 Post-angioplasty Complications -- 5c.5.8 Heart Failure -- 5c.5.9 Heart Rate and Perceived Exertion Use in Heart Failure -- 5c.5.10 Commencing Rehabilitation Prior to Optimisation of Heart Failure Medication -- 5c.6 Emerging Areas Related to Activity Intensity - From Sedentary Behaviour, Light Mobility, and Moderate Intensity to High Intensity Interval Training -- 5c.7 Assessing Functional Capacity and Physical Activity - Guidance, Prescription, and Risk Stratification Outcomes Evaluation and Audit -- 5c.8 Staffing, Core, and Quality Standards -- 5c.8.1 Location of Prevention and Rehabilitation Programmes -- 5c.9 Future Challenges for Exercise in Cardiovascular Disease Prevention and Rehabilitation -- 5c.10 Overarching Guidance -- 5c.11 Specific Physical Activity and Exercise Goals and Guidance -- 5c.12 Specific Exercise Sessions.

5c.13 Programme Outcomes.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.